Search for: "PFIZER INC. v. TEVA PHARMACEUTICALS USA " Results 41 - 60 of 70
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Jan 2012, 6:34 pm by FDABlog HPM
  Akorn’s ANDA, which FDA has not yet tentatively approved, contains a Paragraph IV certification to the ‘269 patent; however, according to the court, non-party Teva Pharmaceuticals USA, Inc. [read post]
18 Jul 2014, 11:55 am
Teva Pharmaceuticals USA, Inc., 2010 WL 2640170, at *2 (W.D. [read post]
6 Apr 2011, 12:18 am by Marie Louise
195/09 Synthon BV v Merz Pharma GmbH & Co KG (The SPC Blog) Amrix (Cyclobenzaprine) – US: Eurand files patent infringement complaint against Anchen in response to Para IV certification (Patent Docs) Asacol (Mesalamine) – US: NJ District Court punts in Asacol DJ action to trigger 180-day exclusivity forfeiture; Rules that subsequent ANDA applicant lacks standing: Medeva Pharma Suisse v Par Pharmaceuticals (FDA Law Blog) Cialis (Tadalafil) – Israel:… [read post]
23 Feb 2008, 4:24 am
In an earlier case, Teva Pharmaceuticals USA v. [read post]
18 Jan 2013, 2:06 pm by Bexis
  The Decherts are too involved in this litigation to comment publicly.There aren’t many research-oriented pharmaceutical companies based in Alabama, and after last week’s execrable decision in Wyeth, Inc. v. [read post]
2 Jun 2011, 12:46 pm by Bexis
Pfizer, Inc., 153 S.W.3d 758, 761 (Ky. 2004) (dictum also extends rule to medical devices). [read post]
17 Mar 2020, 1:32 pm by Noble McIntyre
One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) has been recalled by Teva Pharmaceuticals due to the presence of particulate matter. [read post]
5 Apr 2012, 11:54 am by Bexis
Teva Pharmaceuticals USA, Inc., 2011 WL 4025734, at *3 (S.D. [read post]
22 Jan 2009, 2:06 am
Pfizer Inc., 358 F.3d 659, 661 (9th Cir. 2004) (same; physician considered warning inappropriate) (applying California law).Under these facts, if Conte were an ordinary prescription drug product liability case, plaintiff would have been out of court and out of luck, just like Motus. [read post]
31 Mar 2010, 1:58 pm
Teva Pharm., USA, Inc., 429 F.3d 1364, 1377 (Fed. [read post]
21 Oct 2014, 9:03 am by Dennis Crouch
Teva Pharmaceuticals USA, Inc., the Federal Circuit panel affirmed a lower court finding that BMS’s patent covering the Hep-B drug entecavir is invalid as obvious. [read post]
2 Mar 2012, 6:52 am by Bexis
Pfizer (femoral stem) Deposition1998-09-18 In re AMS Minnesota Penile Prosthesis Litigation Deposition1998-12-22 Ethicon, Inc. v. [read post]